Source: Annals of Oncology. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (TRATAMENTO), GENES
ABNT
ANELLI, A. et al. Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer. Annals of Oncology, v. 14, p. 428-432, 2003Tradução . . Disponível em: https://doi.org/10.1093/annonc/mdg104. Acesso em: 16 nov. 2024.APA
Anelli, A., Brentani, R. R., Gadelha, A. P., Albuquerque, A. A. de, & Soares, F. (2003). Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer. Annals of Oncology, 14, 428-432. doi:10.1093/annonc/mdg104NLM
Anelli A, Brentani RR, Gadelha AP, Albuquerque AA de, Soares F. Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer [Internet]. Annals of Oncology. 2003 ; 14 428-432.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/annonc/mdg104Vancouver
Anelli A, Brentani RR, Gadelha AP, Albuquerque AA de, Soares F. Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer [Internet]. Annals of Oncology. 2003 ; 14 428-432.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/annonc/mdg104